Loading...
B

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 5.66 EUR -2.75% Market Closed
Updated: Mar 30, 2023

Intrinsic Value

The intrinsic value of one BNN stock under the Base Case scenario is 6.61 EUR. Compared to the current market price of 5.66 EUR, BRAIN Biotech AG is Undervalued by 14%.

The Intrinsic Value is calculated as the average of the two valuation methods:

BNN Intrinsic Value
Base Case
6.61 EUR
Undervaluation 14%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Fundamental Analysis

BNN Profitability Score
Profitability Due Diligence

BRAIN Biotech AG's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative Free Cash Flow
Negative 3-Year Average ROIC
Negative Operating Income
32/100
Profitability
Score

BRAIN Biotech AG's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

BNN Solvency Score
Solvency Due Diligence

BRAIN Biotech AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Average Altman Z-Score
Short-Term Liabilities
Long-Term Liabilities
48/100
Solvency
Score

BRAIN Biotech AG's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Financials

Balance Sheet Decomposition
BRAIN Biotech AG

Current Assets 29.1M
Other Current Assets 29.1M
Non-Current Assets 46.4M
Other Non-Current Assets 46.4M
Current Liabilities 19.3M
Other Current Liabilities 19.3M
Non-Current Liabilities 24.5M
Other Non-Current Liabilities 24.5M
Efficiency
55%
Gross Margin
-10%
Operating Margin
-13%
Net Margin
-6%
FCF Margin
Other

BNN Capital Structure
BRAIN Biotech AG

Market Capitalization 129M EUR
Total Debt 0 EUR
Minority Interest 0 EUR
Preferred Equity 0 EUR
Cash and Equivalents 0 EUR
Short-Term Investments 0 EUR
Enterprise Value 129M EUR

Wall St
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 13.04 EUR with a low forecast of 7.07 EUR and a high forecast of 18.9 EUR.

Lowest
Price Target
7.07 EUR
25% Upside
Average
Price Target
13.04 EUR
130% Upside
Highest
Price Target
18.9 EUR
234% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

BNN Competitors
BRAIN Biotech AG

BNN Suppliers & Customers
BRAIN Biotech AG

Suppliers Map
Customers Map

Shareholder Return

BNN Return Decomposition
Main factors of price return

Price Return Decomposition
is not available

It is impossible to break down the market cap return as the net margin from 5 years ago is negative.

What is price return decomposition?

BNN Price
BRAIN Biotech AG

1M 1M
-18%
6M 6M
+28%
1Y 1Y
-34%
3Y 3Y
-7%
5Y 5Y
-76%
Annual Price Range
5.66
52w Low
4.08
52w High
8.8
Price Metrics
Average Annual Return -16.33%
Standard Deviation of Annual Returns 26.63%
Max Drawdown -83%
Shares Statistics
Market Capitalization 129M EUR
Shares Outstanding 21 847 500
Percentage of Shares Shorted
N/A

Company Profile

BRAIN Biotech AG

Country

Germany

Industry

Chemicals

Market Cap

129M EUR

Dividend Yield

0%

Description

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

Contact

HESSEN
Zwingenberg
Darmstaedter Strasse 34-36
+49625193310.0
https://www.brain-biotech.de/

IPO

2016-02-09

Employees

293

Officers

Chairman of the Management Board & CEO
Mr. Adriaan Moelker
Co-Founder
Mr. Ulrich Putsch
CFO & Member of Management Board
Mr. Michael Schneiders
VP of HR & Processes
Dr. Ute Dechert
Consultant
Dr. Jurgen Eck
Exec. VP & Head of Bus. Devel.
Dr. Martin Langer
Show More
Exec. VP and Head of R&D
Dr. Michael Krohn
Head of PR
Thomas Deichmann
Head of Skin Care Bus. Unit
Dr. Michael Waidelich
Head of Group Fin.
Mr. Robbert Michael Hoekstra
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one BNN stock?

The intrinsic value of one BNN stock under the Base Case scenario is 6.61 EUR.

Is BNN stock undervalued or overvalued?

Compared to the current market price of 5.66 EUR, BRAIN Biotech AG is Undervalued by 14%.